Literature DB >> 3621492

Heparin regulates smooth muscle S phase entry in the injured rat carotid artery.

M W Majesky, S M Schwartz, M M Clowes, A W Clowes.   

Abstract

Smooth muscle cell (SMC) proliferation in injured arteries is inhibited by heparin, but the mechanism of inhibition is unknown. In particular, it is not clear whether heparin prevents exit of quiescent SMC from the resting state, inhibits progression through the prereplicative (G1) sequence, or acts during DNA synthesis itself. In this study, induction of ornithine decarboxylase (ODC) activity was used as a marker of SMC entry into the cell cycle in an attempt to localize the site of heparin action during the initial hours after rat carotid injury. Rapid and transient induction of ODC activity was observed that reached a maximum (twenty-three-fold) 6 hours after wounding. Heparin failed to prevent ODC induction but greatly reduced frequencies of [3H]thymidine-labelled SMC nuclei 33 hours after injury. Moreover, heparin infusion could be delayed for up to 18 hours after the injury event with no significant loss of antiproliferative effect. Further delays resulted in marked loss of growth inhibition. The results of these studies show that SMC rapidly and synchronously leave the resting state after injury and suggest that heparin acts late in the prereplicative (G1) sequence or early in S phase to inhibit SMC proliferation in damaged arteries.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3621492     DOI: 10.1161/01.res.61.2.296

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  22 in total

1.  Activation of the NF-kappa B and I kappa B system in smooth muscle cells after rat arterial injury. Induction of vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1.

Authors:  D B Landry; L L Couper; S R Bryant; V Lindner
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

2.  Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery.

Authors:  J Fingerle; R Johnson; A W Clowes; M W Majesky; M A Reidy
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

Review 3.  Pharmacological approaches to the prevention of restenosis following angioplasty. The search for the Holy Grail? (Part II).

Authors:  J P Herrman; W R Hermans; J Vos; P W Serruys
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546

4.  Role of c-fos and E2F in the induction of cyclin A transcription and vascular smooth muscle cell proliferation.

Authors:  A M Sylvester; D Chen; K Krasinski; V Andrés
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

5.  Inhibition of autonomous human keratinocyte proliferation and amphiregulin mitogenic activity by sulfated polysaccharides.

Authors:  P W Cook; P A Mattox; W W Keeble; G D Shipley
Journal:  In Vitro Cell Dev Biol       Date:  1992-03

6.  Heparin-like glycosaminoglycans influence growth and phenotype of human arterial smooth muscle cells in vitro. I. Evidence for reversible binding and inactivation of the platelet-derived growth factor by heparin.

Authors:  G Fager; G Camejo; G Bondjers
Journal:  In Vitro Cell Dev Biol       Date:  1992-03

7.  A heparin sulfate-regulated human keratinocyte autocrine factor is similar or identical to amphiregulin.

Authors:  P W Cook; P A Mattox; W W Keeble; M R Pittelkow; G D Plowman; M Shoyab; J P Adelman; G D Shipley
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

8.  Heparan sulfate Ndst1 regulates vascular smooth muscle cell proliferation, vessel size and vascular remodeling.

Authors:  Neeta Adhikari; David L Basi; Dewayne Townsend; Melissa Rusch; Ami Mariash; Sureni Mullegama; Adrienne Watson; Jon Larson; Sara Tan; Ben Lerman; Jeffrey D Esko; Scott B Selleck; Jennifer L Hall
Journal:  J Mol Cell Cardiol       Date:  2010-03-04       Impact factor: 5.000

9.  Rat carotid artery balloon injury model.

Authors:  David A Tulis
Journal:  Methods Mol Med       Date:  2007

Review 10.  Pharmacological approaches to the prevention of restenosis after coronary angioplasty.

Authors:  M Hamon; E Lécluse; J P Monassier; G Grollier; J C Potier
Journal:  Drugs Aging       Date:  1998-10       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.